Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of a New Method for Instilling Eye Drops
NCT02697318Phase 1Completed
- Sponsor
- University of Waterloo
- Start
- May 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of timolol in Glaucoma (2 arms), sponsored by University of Waterloo. Primary endpoint: Intraocular Pressure at 2 hours. Started May 2016; status: completed.
02
Drugs
timolol
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT02697318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02697318.